Bio-Works Technologies AB (BIOWKS) - Net Assets

Latest as of September 2025: Skr30.04 Million SEK ≈ $3.23 Million USD

Based on the latest financial reports, Bio-Works Technologies AB (BIOWKS) has net assets worth Skr30.04 Million SEK (≈ $3.23 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr52.56 Million ≈ $5.66 Million USD) and total liabilities (Skr22.52 Million ≈ $2.42 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Read total liabilities of Bio-Works Technologies AB for a breakdown of total debt and financial obligations.

Key Net Assets Metrics

Metric Value
Current Net Assets Skr30.04 Million
% of Total Assets 57.16%
Annual Growth Rate 7.94%
5-Year Change 19.03%
10-Year Change N/A
Growth Volatility 120.26

Bio-Works Technologies AB - Net Assets Trend (2015–2024)

This chart illustrates how Bio-Works Technologies AB's net assets have evolved over time, based on quarterly financial data. Also explore Bio-Works Technologies AB (BIOWKS) total assets for the complete picture of this company's asset base.

Annual Net Assets for Bio-Works Technologies AB (2015–2024)

The table below shows the annual net assets of Bio-Works Technologies AB from 2015 to 2024. For live valuation and market cap data, see Bio-Works Technologies AB (BIOWKS) total market value.

Year Net Assets Change
2024-12-31 Skr44.58 Million
≈ $4.80 Million		 +1.25%
2023-12-31 Skr44.03 Million
≈ $4.74 Million		 -34.95%
2022-12-31 Skr67.69 Million
≈ $7.28 Million		 -37.62%
2021-12-31 Skr108.51 Million
≈ $11.68 Million		 +189.69%
2020-12-31 Skr37.46 Million
≈ $4.03 Million		 -54.39%
2019-12-31 Skr82.13 Million
≈ $8.84 Million		 +33.24%
2018-12-31 Skr61.64 Million
≈ $6.63 Million		 -37.93%
2017-12-31 Skr99.32 Million
≈ $10.69 Million		 +320.10%
2016-12-31 Skr23.64 Million
≈ $2.54 Million		 +5.50%
2015-12-31 Skr22.41 Million
≈ $2.41 Million		 --

Equity Component Analysis

This analysis shows how different components contribute to Bio-Works Technologies AB's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 34295900000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Common Stock Skr7.80 Million 17.49%
Other Components Skr379.75 Million 851.76%
Total Equity Skr44.58 Million 100.00%

Bio-Works Technologies AB Competitors by Market Cap

The table below lists competitors of Bio-Works Technologies AB ranked by their market capitalization.

Company Market Cap
SHL Telemedicine Ltd American Depositary Shares
NASDAQ:SHLT
 $33.60 Million
Jentayu Sustainables Bhd
KLSE:5673
 $33.61 Million
Mohenz.Co.Ltd
KQ:006920
 $33.62 Million
Naos Small Cap Opportunities Company Ltd
AU:NSC
 $33.62 Million
Wellbiotec Co. Ltd.
KO:010600
 $33.58 Million
Camino Minerals Corporation
V:COR
 $33.58 Million
TransAct Technologies Incorporated
NASDAQ:TACT
 $33.57 Million
Wintec Co. Ltd
KQ:320000
 $33.57 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Bio-Works Technologies AB's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 44,033,000 to 44,584,000, a change of 551,000 (1.3%).
  • Net loss of 37,357,000 reduced equity.
  • New share issuances of 38,980,000 increased equity.
  • Other factors decreased equity by 1,072,000.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income Skr-37.36 Million -83.79%
Share Issuances Skr38.98 Million +87.43%
Other Changes Skr-1.07 Million -2.4%
Total Change Skr- 1.25%

Book Value vs Market Value Analysis

This analysis compares Bio-Works Technologies AB's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 5.49x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has increased from 2.81x to 5.49x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2015-12-31 Skr1.12 Skr3.14 x
2016-12-31 Skr1.18 Skr3.14 x
2017-12-31 Skr4.94 Skr3.14 x
2018-12-31 Skr3.05 Skr3.14 x
2019-12-31 Skr2.73 Skr3.14 x
2020-12-31 Skr1.23 Skr3.14 x
2021-12-31 Skr3.48 Skr3.14 x
2022-12-31 Skr1.93 Skr3.14 x
2023-12-31 Skr1.22 Skr3.14 x
2024-12-31 Skr0.57 Skr3.14 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Bio-Works Technologies AB utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -83.79%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -146.70%
  • • Asset Turnover: 0.49x
  • • Equity Multiplier: 1.18x
  • Recent ROE (-83.79%) is below the historical average (-67.45%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2015 -55.16% -801.62% 0.06x 1.10x Skr-14.60 Million
2016 -72.57% -466.60% 0.13x 1.19x Skr-19.52 Million
2017 -23.82% -478.40% 0.05x 1.06x Skr-33.59 Million
2018 -61.57% -578.32% 0.10x 1.09x Skr-44.12 Million
2019 -51.28% -755.66% 0.06x 1.07x Skr-50.33 Million
2020 -118.94% -615.83% 0.16x 1.21x Skr-48.29 Million
2021 -11.93% -59.07% 0.18x 1.11x Skr-23.79 Million
2022 -66.40% -108.79% 0.45x 1.35x Skr-51.72 Million
2023 -129.04% -129.44% 0.71x 1.41x Skr-61.22 Million
2024 -83.79% -146.70% 0.49x 1.18x Skr-41.82 Million

Industry Comparison

This section compares Bio-Works Technologies AB's net assets metrics with peer companies in the Biotechnology industry.

Industry Context

  • Industry: Biotechnology
  • Average net assets among peers: $165,054,194
  • Average return on equity (ROE) among peers: -81.86%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Bio-Works Technologies AB (BIOWKS) Skr30.04 Million -55.16% 0.75x $33.60 Million
2cureX AB (2CUREX) $74.34 Million -25.47% 0.06x $4.90 Million
Ascelia Pharma AB (publ) (ACE) $74.33 Million -147.03% 0.17x $40.96 Million
AcouSort AB (ACOU) $15.58 Million -57.51% 0.12x $8.97 Million
Active Biotech AB (ACTI) $188.64 Million -118.73% 1.64x $17.19 Million
Alzinova AB (ALZ) $20.63 Million -16.51% 0.08x $4.97 Million
AlzeCure Pharma (ALZCUR) $182.01 Million -28.02% 0.03x $18.18 Million
Annexin Pharmaceuticals AB (ANNX) $18.81 Million -234.16% 0.42x $11.24 Million
Alligator Bioscience AB (ATORX) $68.52 Million -112.06% 0.43x $14.33 Million
BioInvent International AB (BINV) $219.00 Million -63.86% 0.22x $155.44 Million
BioArctic AB (publ) (BIOA-B) $788.68 Million -15.19% 0.14x $2.59 Billion

About Bio-Works Technologies AB

ST:BIOWKS Sweden Biotechnology
Market Cap
$33.60 Million
Skr312.19 Million SEK
Market Cap Rank
#23341 Global
#448 in Sweden
Share Price
Skr3.14
Change (1 day)
+1.29%
52-Week Range
Skr1.26 - Skr3.80
All Time High
Skr28.60
Categories
Companies in Sweden Biotechnology
About

Bio-Works Technologies AB (publ), together with its subsidiaries, engages in the manufactures and sale of chromatography resins for the purification of biopharmaceuticals in Sweden. The company offers affinity and activated resin, hydrophobic interaction chromatography (HIC) resins, GoBio Mini and GoBio prepacked columns, ion exchange chromatography (IEX) resin, immobilized metal-ion affinity chr… Read more